Clinical Trial Update: Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is testing thalidomide for symptomatic large granular lymphocytic leukemia and related NK-LGL leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer Cell Large Granular Lymphocytic Leukemia
• T-cell Large Granular Lymphocytic Leukemia

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: T-LGL Leukemia, NK-LGL Leukemia | Phase 2 | Status: RECRUITING